Skip to main content
SpringerLink
Log in

Increased rat femur osteocalcin mRNA concentrations following in vivo administration of thyroid hormone

  • Comment
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thyroid hormone has a direct resorptive effect on bone. Thyroid hormone therapy in doses that suppress pituitary TSH production result in a reduction in bone density. Osteocalcin is a bone matrix protein. Serum levels are a sensitive marker for bone turnover and are increased in hyperthyroid patients. In order to establish an animal model to study the effects of thyroid hormone on bone turnover, we measured rat femur osteocalcin mRNA following in vivo administration of thyroid hormone. Young CD rats weighing 60–90 g were given daily ip injections of T3, T4, or saline (control) for 12 days. Blood was obtained for radioimmunoassays, and RNA was extracted from femurs and analyzed by Northern blot using a 60-mer synthetic oligonucleotide probe corresponding to bases 360–420 of rat osteocalcin mRNA, labeled with [32P] ATP by 5′-endlabeling. Serum TSH concentrations were suppressed to subnormal levels by the lowest doses of T3 and T4, and to undetectable levels by the higher doses. Increases in serum T3 and T4 concentrations were proportional to the dose of each administered hormone. T3, 5 and 10 µg/100 g body weight, resulted in a 43% and 62% increase in osteocalcin mRNA, respectively. T4, 5, 10, and 20 µg/100 g body weight, resulted in a 35%, 47%, and 135% increase in osteocalcin mRNA, respectively. These data demonstrate that in vivo administration of either T4 or T3 to young rats results in a significant dose-dependent increase in femur osteocalcin mRNA concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mundy G.R., Shapiro J.L., Bandelin J.C., Canalis E.M., Raisz L.G. Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 58: 529, 1976.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Auwerx J., Bouillon R. Mineral and bone metabolism in thyroid disease: A review. Quart. J. Med. 60: 737, 1986.

    PubMed  CAS  Google Scholar 

  3. Epstein S. Serum and urinary markers of bone remodelling: Assessment of bone turnover. Endocr. Rev. 9: 437, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. Garrel D.R., Delmas P.D., Malavai L., Tourniaare J. Serum bone Gla protein: A marker of bone turnover in hyperthyroidism. J. Clin. Endocrinol. Metab. 62: 1052, 1986.

    Article  PubMed  CAS  Google Scholar 

  5. Lukert B.P., Higgins J.C., Stoskopf M.M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J. Clin. Endocrinol. Metab. 62: 1056, 1986.

    Article  PubMed  CAS  Google Scholar 

  6. Martinez M.E., Herranz L., de Pedro C., Pallardo L.F. Osteocalcin levels in patients with hyper- and hypothyroidism. Horm. Metab. Res. 18: 212, 1986.

    Article  PubMed  CAS  Google Scholar 

  7. Johansen J.S., Thomsen K., Christiansen C. A radioimmunity for bone Gla protein (BGP) in human plasma. Acta Endocrinol. (Copenh.) 114: 410, 1987.

    CAS  Google Scholar 

  8. Lee M.S., Kim S.Y., Lee M.C., Cho B.Y., Lee H.K., Koh C-S., Min H.K. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 70: 766, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Faber J., Perrild H., Johansen J.S. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: Parameters for metabolic status at the tissue level. J. Clin. Endocrinol. Metab. 70: 49, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. Ross D.S., Ardisson L.J., Nussbaum S.R., Meskell M.J. Serum osteocalcin in patients taking I-thyroxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 72: 507, 1991.

    Article  PubMed  CAS  Google Scholar 

  11. Kieffer J.D., Mover H., Federico P., Maloof F. Pituitary-thyroid axis in neonatal and adult rats: comparison of the sexes. Endocrinology 98: 295, 1976.

    Article  PubMed  CAS  Google Scholar 

  12. Gautvik K.M.-, Tashjian A.H., Kourides I.A., Weintraub B.D., Graeber C.T., Maloof F., Suzuki K., Zuckerman J.E. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling. N. Engl. J. Med. 290: 1162, 1974.

    Article  PubMed  CAS  Google Scholar 

  13. Ridgway E.C., Weintraub B.D., Cevallos J.L., Rack C., Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J. Clin. Invest. 52: 2783, 1973.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294, 1979.

    Article  PubMed  CAS  Google Scholar 

  15. Thomas P.S. Hybridization of denaturated RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77: 5201, 1980.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  16. Maxam A.M., Gilbert W. Sequence end-labeled DNA with base specific chemical cleavages. Methods Enzymol. 65: 499, 1980.

    Article  PubMed  CAS  Google Scholar 

  17. Duncan D.B. Multiple range and multiple tests. Biometrics 11: 1, 1985.

    Article  Google Scholar 

  18. Ross D.S., Neer R.M., Ridgway E.C., Daniels G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thryoxine. Am. J. Med. 82: 1167, 1987.

    Article  PubMed  CAS  Google Scholar 

  19. Paul T.L., Kerrigan J., Kelly A.M., Braverman L.E., Baran D.T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259: 3137, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Klaushofer K., Hoffman O., Gleispach H., Leis H-J., Czerwenka E., Koller K., Peterlik M. Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J. Bone Min. Res. 4: 305, 1989.

    Article  CAS  Google Scholar 

  21. Soskolne W.A., Schwartz Z., Goldstein M., Ornoy A. The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone remodelling of mouse long bone in vitro. Bone 11: 301, 1990.

    Article  PubMed  CAS  Google Scholar 

  22. Rizzoli R., Poser J., Bürgi U. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 35: 71, 1986.

    Article  PubMed  CAS  Google Scholar 

  23. Sato K., Han D.C., Fujii Y., Tsushiba T., Shizume K. Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osetoblastic cells (ROS 17/2.8) through 3, 5, 3′-triiodo-L-thyronine nuclear receptors. Endocrinology 120: 1873, 1987.

    Article  PubMed  CAS  Google Scholar 

  24. LeBron B.A., Pekary A.E., Mirell C., Hahn T.J., Hershman J.M. Thyroid hormone 5′-deiodinase activity, nuclear binding, and effects on mitogenesis in UMR-106 osteoblastic osteosarcoma cells. J. Bone Min. Res. 4: 173, 1989.

    Article  CAS  Google Scholar 

  25. Kasono K., Sato K., Han D.C., Fujii Y., Tsushima T., Shizume K. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possibile mechanism of hyper-alkaline phosphatasia in hyperthyroidism. Bone Min. 4: 355, 1988.

    CAS  Google Scholar 

  26. Kaplan M.M. The role of thyroid hormone deiodination in the regulation of hypothalamo-pituitary function. Neuroendocrinology 38: 254, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. High W.B., Capen C.C., Black H.E. Effects of thyroxine on cortical bone remodelling in adult dogs. A histomorphometric study. Am. J. Pathol. 102: 438, 1981.

    PubMed Central  PubMed  CAS  Google Scholar 

  28. Demay M.B., Roth D.A., Kronenberg H.M. Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on Gene transcription. J. Biol. Chem. 264: 2279, 1989.

    PubMed  CAS  Google Scholar 

  29. Lian J., Stewart C., Puchacz E., Mackowiak S., Shalhoud V., Collart D., Zambetti G., Stein G. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl. Acad. Sci USA 86: 1143, 1989.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Morrison N.A., Shine J., Fragonas J-C., Verkest V., McMenemy M.L., Eismam J.A. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246: 1158, 1989.

    Article  PubMed  CAS  Google Scholar 

  31. Bouillion R., Muls E., De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J. Clin. Endocrinol. Metab. 51: 793, 1980.

    Article  Google Scholar 

  32. Weisman Y., Eisenberg Z., Lubelski R., Spirer Z., Edelstein S., Harell A. Decreased 1,25-dihydroxycholecalciferol and increased 25-hydroxy- and 24, 25-dihydroxycholecalciferol in tissues of rats treated with thyroxine. Calcif. Tissue Int. 33: 445, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Kano K., Jones G. Direct in vitro effect of thyroid hormones on 25-hydroxyvitamin D3 metabolism in the perfused rat kidney. Endocrinology 114: 330, 1984.

    Article  PubMed  CAS  Google Scholar 

  34. Mackowiak S., Gerstenfeld L.C. Effect of thyroid hormone on osteocalcin synthesis. J. Bone Min. Res. 3: S172, 1988 (Abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thyroid Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Douglas S. Ross M.D. & R. Graichen

Authors
  1. Douglas S. Ross M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Graichen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by NIH Grant DK-01415

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, D.S., Graichen, R. Increased rat femur osteocalcin mRNA concentrations following in vivo administration of thyroid hormone. J Endocrinol Invest 14, 763–766 (1991). https://doi.org/10.1007/BF03347911

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347911

Key-words

Search

Navigation